Evaluating the performance of existing tools to predict clinically significant prostate cancer in men with indeterminate lesions on biparametric MRI and development of a novel multiplex model: a prospective cohort study
STHLM3-MRI clinical trial is funded by the Swedish Cancer Society (Cancerfonden), the Swedish Research Council (Vetenskapsrådet), the Swedish Research Council for Health Working Life and Welfare (FORTE), the Strategic Research Programme on Cancer (StratCan), Hagstrandska Minnesfonden, Region Stockholm, Svenska Druidorden, Åke Wibergs Stiftelse, the Swedish e-Science Research Centre, the Karolinska Institutet, and Prostatacancerförbundet.
Authors
- Ugo Giovanni Falagario (ORCID: https://orcid.org/0000-0002-1152-3005)
- Henrik Grönberg (ORCID: https://orcid.org/0000-0002-1073-2753)
- Tobias Nordström (ORCID: https://orcid.org/0000-0003-4915-7546)
- Jan Chandra Engel (ORCID: https://orcid.org/0000-0001-7934-2449)
- Fredrik Jäderling (ORCID: https://orcid.org/0000-0002-9042-7328)
- Anna Lantz (ORCID: https://orcid.org/0000-0002-5335-8028)
- Lars Björnebo (ORCID: https://orcid.org/0000-0002-5573-0794)
- Thorgerdur Palsdottir (ORCID: https://orcid.org/0000-0003-3491-3986)
- Martin Eklund (ORCID: https://orcid.org/0000-0001-5032-5266)
- Ahmad Abbadi (ORCID: https://orcid.org/0000-0001-9373-668X)
- Andrea Discacciati
Institutions
- University of Foggia (IT)
- Danderyds sjukhus (SE)
- Karolinska Institutet (SE)
- Saint Göran Hospital (SE)
- Glanrhyd Hospital (GB)
Publication Details
- Journal
- EClinicalMedicine
- Published
- 2025-04-01
- DOI
- https://doi.org/10.1016/j.eclinm.2025.103191
- Citations
- 3
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 4.56